X-2907540-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_001669.4(ARSD):c.1513G>A(p.Gly505Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 1,178,000 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 41 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.00010 ( 0 hom. 39 hem. )
Consequence
ARSD
NM_001669.4 missense
NM_001669.4 missense
Scores
3
9
5
Clinical Significance
Conservation
PhyloP100: 2.97
Genes affected
ARSD (HGNC:717): (arylsulfatase D) The protein encoded by this gene is a member of the sulfatase family. Sulfatases are essential for the correct composition of bone and cartilage matrix. The encoded protein is postranslationally glycosylated and localized to the lysosome. This gene is located within a cluster of similar arylsulfatase genes on chromosome X. A related pseudogene has been identified in the pseudoautosomal region of chromosome Y. [provided by RefSeq, Jul 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.844
BS2
High Hemizygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARSD | NM_001669.4 | c.1513G>A | p.Gly505Arg | missense_variant | 10/10 | ENST00000381154.6 | NP_001660.2 | |
ARSD | XM_005274514.3 | c.1378G>A | p.Gly460Arg | missense_variant | 9/9 | XP_005274571.1 | ||
ARSD | XM_047442108.1 | c.1375G>A | p.Gly459Arg | missense_variant | 10/10 | XP_047298064.1 | ||
ARSD | XM_005274515.3 | c.*437G>A | 3_prime_UTR_variant | 10/10 | XP_005274572.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARSD | ENST00000381154.6 | c.1513G>A | p.Gly505Arg | missense_variant | 10/10 | 1 | NM_001669.4 | ENSP00000370546 | P1 | |
ARSD | ENST00000458014.1 | c.319G>A | p.Gly107Arg | missense_variant | 3/4 | 3 | ENSP00000409180 | |||
ARSD | ENST00000495294.1 | n.648G>A | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000115 AC: 13AN: 112968Hom.: 0 Cov.: 23 AF XY: 0.0000570 AC XY: 2AN XY: 35102
GnomAD3 genomes
AF:
AC:
13
AN:
112968
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
35102
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000123 AC: 16AN: 130600Hom.: 0 AF XY: 0.000127 AC XY: 4AN XY: 31610
GnomAD3 exomes
AF:
AC:
16
AN:
130600
Hom.:
AF XY:
AC XY:
4
AN XY:
31610
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000995 AC: 106AN: 1065032Hom.: 0 Cov.: 31 AF XY: 0.000115 AC XY: 39AN XY: 338888
GnomAD4 exome
AF:
AC:
106
AN:
1065032
Hom.:
Cov.:
31
AF XY:
AC XY:
39
AN XY:
338888
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000115 AC: 13AN: 112968Hom.: 0 Cov.: 23 AF XY: 0.0000570 AC XY: 2AN XY: 35102
GnomAD4 genome
AF:
AC:
13
AN:
112968
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
35102
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
17
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 12, 2024 | The c.1513G>A (p.G505R) alteration is located in exon 10 (coding exon 10) of the ARSD gene. This alteration results from a G to A substitution at nucleotide position 1513, causing the glycine (G) at amino acid position 505 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D;.
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;.
Vest4
MutPred
Loss of glycosylation at S504 (P = 0.0455);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at